Publications

Conradt G, Hausser I, Nyström A. 2023. Epidermal or Dermal Collagen VII Is Sufficient for Skin Integrity: Insights to Anchoring Fibril Homeostasis. J Invest Dermatol. 2023 Nov 24:S0022-202X(23)03102-0. doi: 10.1016/j.jid.2023.11.003.

Böhm S, Wustrau K, Pachlopnik Schmid J, Prader S, Ahlman M, Yacobovich J, Beier R, Speckmann C, Behnisch W, Ifversen M, Jordan MB, Marsh RA, Naumann-Bartsch N, Mauz-Koerholz C, Honig M, Schulz AS, Malinowska I, Hines MR, Nichols KE, Gil-Herrera J, Talano JA, Crooks B, Formankova R, Jorch N, Bakhtiar S, Kühnle I, Streiter M, Nathrath M, Russo A, Duerken M, Lang P, Lindemans CA, Henter JI, Lehmberg K, Ehl S. 2023. Survival in primary hemophagocytic lymphohistiocytosis 2016-2021: etoposide is better than its reputation. Blood. Nov 22:blood.2023022281. doi: 10.1182/blood.2023022281.

Caceres L, Abogunloko T, Malchow S, Ehret F, Merz J, Li X, Sol Mitre L, Magnani N, Tasat D, Mwinyella T, Spiga L, Suchanek D, Fischer L, Gorka O, Colin Gissler M, Hilgendorf I, Stachon P, Rog-Zielinska E, Groß O, Westermann D, Evelson P, Wolf D, Marchini T. 2023. Molecular mechanisms underlying NLRP3 inflammasome activation and IL-1β production in air pollution fine particulate matter (PM2.5)-primed macrophages. Environ Pollut. 2023 Nov 22;341:122997. doi: 10.1016/j.envpol.2023.122997.

Uzel, G., B. Keller, and K. Warnatz. 2023. Hypogammaglobulinemia and immune dysregulation – not just two sides of a coin. J Allergy Clin Immunol. doi:10.1016/j.jaci.2023.11.005.

Rensing-Ehl, A., M. R. Lorenz, M. Fuhrer, W. Willenbacher, E. Willenbacher, S. Sopper, M. Abinun, M. E. Maccari, C. Konig, P. Haegele, S. Fuchs, C. Castro, P. Kury, O. Pelle, C. Klemann, M. Heeg, J. Thalhammer, O. Wegehaupt, M. Fischer, S. Goldacker, B. Schulte, S. Biskup, P. Chatelain, V. Schuster, K. Warnatz, B. Grimbacher, A. Meinhardt, D. Holzinger, P. T. Oommen, T. Hinze, H. Hebart, K. Seeger, K. Lehmberg, T. R. Leahy, A. Claviez, S. Vieth, F. H. Schilling, I. Fuchs, M. Gross, F. Rieux-Laucat, A. Magerus, C. Speckmann, K. Schwarz, S. Ehl, and A. s. group. 2023. Abnormal biomarkers predict complex FAS or FADD defects missed by exome sequencing. J Allergy Clin Immunol. doi:10.1016/j.jaci.2023.11.006.

Magerus, A., A. Rensing-Ehl, V. K. Rao, D. Teachey, F. Rieux-Laucat, and S. Ehl. 2023. Autoimmune-lymphoproliferative immunodeficiencies (ALPID) A proposed approach to redefining ALPS and other lymphoproliferative immune disorders. J Allergy Clin Immunol. doi:10.1016/j.jaci.2023.11.004.

Wu, Y., P. M. A. Zehnle, J. Rajak, N. Koleci, G. Andrieux, L. Gallego-Villar, K. Aumann, M. Boerries, C. M. Niemeyer, C. Flotho, S. Bohler, and M. Erlacher. 2023. BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia. Leukemia. doi:10.1038/s41375-023-02079-5.

Ramamoorthy, S., D. Lebrecht, D. Schanze, I. Schanze, I. Wieland, G. Andrieux, P. Metzger, M. Hess, M. H. Albert, A. Borkhardt, D. Bresters, J. Buechner, A. Catala, V. De Haas, M. Dworzak, M. Erlacher, H. Hasle, K. Jahnukainen, F. Locatelli, R. Masetti, J. Stary, D. Turkiewicz, L. Vinci, M. W. Wlodarski, A. Yoshimi, M. Boerries, C. M. Niemeyer, M. Zenker, and C. Flotho. 2023. Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup. Br J Haematol. doi:10.1111/bjh.19190.

Rolles, B., A. Caballero-Oteyza, M. Proietti, S. Goldacker, K. Warnatz, N. Camacho-Ordonez, S. Prader, J. P. Schmid, M. Vieri, S. Isfort, R. Meyer, M. Kirschner, T. H. Brummendorf, F. Beier, and B. Grimbacher. 2023. Telomere biology disorders may manifest as common variable immunodeficiency (CVID). Clin Immunol 257: 109837. doi:10.1016/j.clim.2023.109837.

Velasco Cárdenas RM, Brandl SM, Meléndez AV, Schlaak AE, Buschky A, Peters T, Beier F, Serrels B, Taromi S, Raute K, Hauri S, Gstaiger M, Lassmann S, Huppa JB, Boerries M, Andrieux G, Bengsch B, Schamel WW, Minguet S. 2023. Harnessing CD3 diversity to optimize CAR T cells. Nat Immunol. 24(12):2135-2149. doi: 10.1038/s41590-023-01658-z.

Wogram E, Prinz M. 2023. APOE set the microglia free. Nat Immunol. 24(11):1790-1791. doi: 10.1038/s41590-023-01651-6.

Nelde A, Schuster H, Heitmann JS, Bauer J, Maringer Y, Zwick M, Volkmer JP, Chen JY, Stanger AMP, Lehmann A, Appiah B, Märklin M, Rücker-Braun E, Salih HR, Roerden M, Schroeder SM, Häring MF, Schlosser A, Schetelig J, Schmitz M, Boerries M, Köhler N, Lengerke C, Majeti R, Weissman IL, Rammensee HG, Walz JS. 2023. Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells. Blood Cancer Discov. 4(6):468-489. doi: 10.1158/2643-3230.BCD-23-0020.

Peng XP, Al-Ddafari MS, Caballero-Oteyza A, El Mezouar C, Mrovecova P, Dib SE, Massen Z, Smahi MC, Faiza A, Hassaïne RT, Lefranc G, Aribi M, Grimbacher B. 2023. Next generation sequencing (NGS)-based approach to diagnosing Algerian patients with suspected inborn errors of immunity (IEIs). Clin Immunol. 256:109758. doi: 10.1016/j.clim.2023.109758.

Apostolova P, Kreutmair S, Toffalori C, Punta M, Unger S, Burk AC, Wehr C, Maas-Bauer K, Melchinger W, Haring E, Hoefflin R, Shoumariyeh K, Hupfer V, Lauer EM, Duquesne S, Lowinus T, Gonzalo Núñez N, Alberti C, da Costa Pereira S, Merten CH, Power L, Weiss M, Böke C, Pfeifer D, Marks R, Bertz H, Wäsch R, Ihorst G, Gentner B, Duyster J, Boerries M, Andrieux G, Finke J, Becher B, Vago L, Zeiser R. 2023. Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response. Br J Haematol. 2023 Oct;203(2):264-281. doi: 10.1111/bjh.19007.

Ochoa S, Abers MS, Rosen LB, Rump A, Howe K, Lieberman JA, Wright BL, Suez D, Krausz M, Grimbacher B, Lionakis MS, Uzel G. 2023. Management and outcome of COVID-19 in CTLA-4 insufficiency. Blood Adv. 7(19):5743-5751. doi: 10.1182/bloodadvances.2023010105.

Maccari ME, Wolkewitz M, Schwab C, Lorenzini T, Leiding JW, Aladjdi N, Abolhassani H, Abou-Chahla W, Aiuti A, Azarnoush S, Baris S, Barlogis V, Barzaghi F, Baumann U, Bloomfield M, Bohynikova N, Bodet D, Boutboul D, Bucciol G, Buckland MS, Burns SO, Cancrini C, Cathébras P, Cavazzana M, Cheminant M, Chinello M, Ciznar P, Coulter TI, D’Aveni M, Ekwall O, Eric Z, Eren E, Fasth A, Frange P, Fournier B, Garcia-Prat M, Gardembas M, Geier C, Ghosh S, Goda V, Hammarström L, Hauck F, Heeg M, Heropolitanska-Pliszka E, Hilfanova A, Jolles S, Karakoc-Aydiner E, Kindle GR, Kiykim A, Klemann C, Koletsi P, Koltan S, Kondratenko I, Körholz J, Krüger R, Jeziorski E, Levy R, Le Guenno G, Lefevre G, Lougaris V, Marzollo A, Mahlaoui N, Malphettes M, Meinhardt A, Merlin E, Meyts I, Milota T, Moreira F, Moshous D, Mukhina A, Neth O, Neubert J, Neven B, Nieters A, Nove-Josserand R, Oksenhendler E, Ozen A, Olbrich P, Perlat A, Pac M, Schmid JP, Pacillo L, Parra-Martinez A, Paschenko O, Pellier I, Sefer AP, Plebani A, Plantaz D, Prader S, Raffray L, Ritterbusch H, Riviere JG, Rivalta B, Rusch S, Sakovich I, Savic S, Scheible R, Schleinitz N, Schuetz C, Schulz A, Sediva A, Semeraro M, Sharapova SO, Shcher…See abstract for full author list. 2023. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity. J Allergy Clin Immunol. Oct;152(4):984-996.e10. doi: 10.1016/j.jaci.2023.06.015.